Briacell Therapeutics Corp (BCT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19 | 147 | 720 | 1,015 | 132 |
| Marketable Securities | N/A | 0 | 1,029 | 602 | 689 |
| Receivables | 21 | 3 | 15 | 6 | 3 |
| TOTAL | $239 | $157 | $1,877 | $1,634 | $833 |
| Non-Current Assets | |||||
| Intangibles | 239 | 258 | 275 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 133 | 2 | 2 |
| TOTAL | $239 | $258 | $407 | $2 | $2 |
| Total Assets | $478 | $415 | $2,285 | $1,636 | $836 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 229 | 301 | 1,121 | N/A | N/A |
| TOTAL | $3,630 | $1,059 | $1,340 | $886 | $49 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 0 | 507 | N/A |
| TOTAL | $143 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,773 | $1,059 | $1,340 | $886 | $49 |
| Shareholders' Equity | |||||
| Common Shares | 11,230 | 10,382 | 7,839 | 5,303 | 3,437 |
| Retained earnings | -16,642 | -13,781 | -9,739 | -6,682 | -4,273 |
| Other shareholders' equity | 2,117 | 2,755 | 2,845 | 2,129 | 1,623 |
| TOTAL | $-3,294 | $-643 | $945 | $750 | $787 |
| Total Liabilities And Equity | $478 | $415 | $2,285 | $1,636 | $836 |